Harold Varmus has been sworn in as director of the National Cancer Institute of the National Institutes of Health. Most recently, he was the president of Memorial Sloan-Kettering Cancer Center in New York. Before that, from 1993 until 1999, he was the director of NIH, and prior to that, he spent 23 years as a faculty member at the University of California, San Francisco, medical school. In 1989, Varmus received the Nobel Prize in physiology or medicine for studies of the genetic basis of cancer.
Alan Goldberg was elected this week to Pressure BioSciences' board of directors, filling an open Class III that had been vacant since shareholders voted to amend the company's articles of incorporation and to divide the board of directors into three classes.
Goldberg has been an investor in the company since 2007. He is a long-term member of the Chicago Board of Trade and chairman of a large investment fund.